AACR logo

More articles from Poster Presentations - Combination Immunotherapies

Abstract 6630: Synergistic immuno photothermal nanotherapy (SYMPHONY) for combination cancer therapy
Yang Liu, Paolo Maccarini, Gregory M. Palmer, Brant A. Inman, Peter E. Fecci, Tuan Vo-Dinh

Cancer Research Aug 2020, 80 (16 Supplement) 6630; DOI: 10.1158/1538-7445.AM2020-6630
Abstract 6645: Anti-EGF antibodies significantly improve the activity of RET, BRAF, MEK and PI3K kinase inhibitors in preclinical models
Silvia Garcia Roman, Jordi Codony Servat, Miguel Angel Molina Vila, Jordi Bertran Alamillo, Monica Garzon, Alejandro Martínez Bueno, Santiago Viteri, María González Cao, Andrés Aguilar, Juan José García, Erik d'Hondt, Rafael Rosell

Cancer Research Aug 2020, 80 (16 Supplement) 6645; DOI: 10.1158/1538-7445.AM2020-6645
Abstract 6641: In situ immunization with the TLR9-agonist CMP-001 enhances anti-PD1 therapy in head and neck tumors
Yinwen Cheng, Caitlin D. Lemke-Miltner, Carlos H. Chan, Aliasger Salem, George Weiner, Andrean Simons

Cancer Research Aug 2020, 80 (16 Supplement) 6641; DOI: 10.1158/1538-7445.AM2020-6641
Abstract 6652: Employing ex vivo 3D-Screen technology for the development of rational combinations of immuno-oncology drugs in tumor organoids of fresh patient tissue
Vijayendra Agrawal, Mibel M. Pabón, Jared C. Ehrhart, Tina Pastoor, Jenny M. Kreahling, Soner Altiok

Cancer Research Aug 2020, 80 (16 Supplement) 6652; DOI: 10.1158/1538-7445.AM2020-6652
Abstract 6647: Sensitizing microsatellite stable colorectal cancer to immune checkpoint therapy utilizing Wnt pathway inhibition
Stacey M. Bagby, Sarah J. Hartman, Natalie M. Navarro, Betelehem W. Yacob, Jeremy Shulman, Jessica Barkow, Christopher H. Lieu, S. Lindsey Davis, Alexis D. Leal, Wells A. Messersmith, Angela Minic, Kimberly R. Jordan, Julie Lang, Todd M. Pitts

Cancer Research Aug 2020, 80 (16 Supplement) 6647; DOI: 10.1158/1538-7445.AM2020-6647
Abstract 6646: Comprehensive cyclic immunofluorescent analysis reveals new target candidates for CAR T cell based immunotherapy of glioblastoma multiforme
Sandy Reiß, Stefan Tomiuk, Jutta Kollet, Jan Drewes, Melanie Jungblut, Andreas Bosio

Cancer Research Aug 2020, 80 (16 Supplement) 6646; DOI: 10.1158/1538-7445.AM2020-6646
Abstract 6637: Inhibition of FGFR signaling by lenvatinib activates tumor interferon gamma signaling pathway and potentiates antitumor activity of anti-PD-1 antibody
Yusuke Adachi, Hiroshi Kamiyama, Kenji Ichikawa, Yoichi Ozawa, Sayo Fukushima, Satoshi Goda, Shogo Yamaguchi, Masahiro Matsuki, Saori Watanabe Miyano, Akira Yokoi, Yu Kato, Yasuhiro Funahashi

Cancer Research Aug 2020, 80 (16 Supplement) 6637; DOI: 10.1158/1538-7445.AM2020-6637
Abstract 6651: Combination of hetIL-15 with chemotherapy in triple negative breast and pancreatic cancer mouse models increases tumor necrosis and alleviates metastatic disease
Dimitris Stellas, Vasiliki Stravokefalou, Sevasti Karaliota, Bethany Nagy, Serguei Koslov, Konstantinos Dimas, Barbara K. Felber, George N. Pavlakis

Cancer Research Aug 2020, 80 (16 Supplement) 6651; DOI: 10.1158/1538-7445.AM2020-6651
Abstract 6650: Targeted radiation in combination with immunotherapy agents in murine breast cancer models
Sumithra Urs, David Draper, Maryland R. Franklin

Cancer Research Aug 2020, 80 (16 Supplement) 6650; DOI: 10.1158/1538-7445.AM2020-6650
Abstract 6640: Stabilized recombinant trefoil factor 2 (TFF2-CTP) enhances anti-tumor activity of PD-1 blockade in mouse models of colorectal cancer
Woosook Kim, Na Fu, Phaneendra Duddempudi, Zinaida Dubeykovskaya, Steven Almo, Chandan Guha, Seth Lederman, Timothy Wang

Cancer Research Aug 2020, 80 (16 Supplement) 6640; DOI: 10.1158/1538-7445.AM2020-6640

Main menu

User menu

Search

More articles from Poster Presentations - Combination Immunotherapies

Pages

Articles

Info for

About Cancer Research